The first report of significantly improvement of NT-proBNP level in rheumatoid arthritis patients treated with tofacitinib during 12-month follow-up.
2 September 2019 (14:00 - 18:00)
Organised by:
Abstract
Slides
About the speaker
A.S. Loginov Moscow Clinical Research and Practical Centre, Moscow (Russian Federation)
7 More presentations in this session
Access the full session
The Event
ESC Congress 2019
2 September 2019
14:00 CET
